Aortic diseases encompass a diverse range of medical conditions affecting the aorta, a crucial blood vessel responsible for distributing oxygenated blood throughout the body. These conditions, which include aortic aneurysms, dissections, and various structural abnormalities, can have profound implications for cardiovascular health. Addressing aortic diseases requires a comprehensive approach, often involving a combination of monitoring, medical intervention, and, in some cases, surgical procedures. As our understanding of the complexities of aortic diseases advances, healthcare professionals are continually refining diagnostic tools and treatment modalities to provide more precise and tailored care for patients. Ongoing research in this field seeks to uncover new insights into the causes of aortic diseases, fostering the development of innovative therapies that aim to improve patient outcomes and overall cardiovascular well-being. The collaborative efforts of clinicians, researchers, and medical professionals remain pivotal in advancing our ability to address the challenges posed by aortic diseases and enhance the quality of care for affected individuals.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation